Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22528210 | 1.00 | ALDH1A1 (0.39) | ALDH1A1MEN1KMT2ALMNATSHR | |
| SCHEMBL12685847 | 0.79 | MEN1 (0.32) | ALDH1A1MEN1KMT2A | |
| SCHEMBL24497281 | 0.75 | TSHR (0.34) | ALDH1A1MEN1KMT2ALMNATSHR | |
| SCHEMBL21470638 | 0.74 | — | — | |
| SCHEMBL14198620 | 0.72 | — | — | |
| SCHEMBL19630862 | 0.71 | — | — | |
| SCHEMBL23728206 | 0.71 | LMNA (0.46) | ALDH1A1MEN1KMT2ALMNATSHR | |
| SCHEMBL13468803 | 0.71 | TSHR (0.36) | TSHR | |
| SCHEMBL25217392 | 0.70 | — | — | |
| SCHEMBL19676822 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115047127-B | Method for identifying NFC and FC orange juice by utilizing volatile metabonomics technology | 中国检验检疫科学研究院 | 2024-03-08 | — | — | CN | claimed |
| CN-115047127-A | Method for identifying NFC and FC orange juice by utilizing volatile metabonomics technology | 中国检验检疫科学研究院 | 2022-09-13 | — | — | CN | claimed |
| CN-113456626-B | Xanthine oxidase inhibitor and screening method and application thereof | 吉林大学 | 2022-05-06 | — | — | CN | claimed |
| US-20210163387-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | TRUSTEES OF BOSTON UNIVERSITY (US) | 2021-06-03 | — | — | US | claimed |
| US-10981850-B2 | One-step flow-mediated synthesis of cannabidiol (CBD) and derivatives | TRUSTEES OF BOSTON UNIVERSITY (US) | 2021-04-20 | — | — | US | claimed |
| WO-2021050786-A1 | CANNABIN OID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF | CALIFORNIA AMBER INC. (US) | 2021-03-18 | — | — | WO | claimed |
| US-20210068444-A1 | CANNABINOID COMPOSITIONS WITH IMPROVED ORGANOLEPTIC AND THERAPEUTIC PROPERTIES, METHOD OF PRODUCTION, AND USE THEREOF | CALIFORNIA AMBER INC. | 2021-03-11 | — | — | US | claimed |
| WO-2020214574-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | TRUSTEES OF BOSTON UNIVERSITY (US) | 2020-10-22 | — | — | WO | claimed |
| US-20200325091-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | TRUSTEES OF BOSTON UNIVERSITY (US) | 2020-10-15 | — | — | US | claimed |
| US-20200101041-A1 | METHODS AND COMPOSITIONS FOR ENHANCING HEALTH | OJAI ENERGETICS PBC | 2020-04-02 | — | — | US | claimed |
| EP-3600271-A1 | METHODS AND COMPOSITIONS FOR ENHANCING HEALTH | Ojai Energetics PBC (US) | 2020-02-05 | — | — | EP | claimed |
| CN-110709069-A | Methods and compositions for enhancing health | 奥海能量公益公司 | 2020-01-17 | — | — | CN | claimed |
| WO-2018183115-A1 | METHODS AND COMPOSITIONS FOR ENHANCING HEALTH | OJAI ENERGETICS PBC (US) | 2018-10-04 | — | — | WO | claimed |
| EP-3881048-B1 | DEVICE FOR REMOVING VOLATILE ORGANIC COMPOUNDS | LETAT FRANCAIS REPRESENTE PAR LE MINI DE LINTERIEUR (FR) | 2026-05-06 | — | — | EP | disclosed |
| US-20260021121-A1 | CANNABIS COMPOSITIONS AND METHODS | AIP ASSET MANAGEMENT INC. (CA) | 2026-01-22 | — | — | US | disclosed |
| US-12129429-B1 | Method for paraffin inhibiting | Skaiblue Fund LLC | 2024-10-29 | — | — | US | disclosed |
| US-20200101041-A1 | METHODS AND COMPOSITIONS FOR ENHANCING HEALTH | OJAI ENERGETICS PBC | 2020-04-02 | — | — | US | disclosed |
| EP-3600271-A1 | METHODS AND COMPOSITIONS FOR ENHANCING HEALTH | Ojai Energetics PBC (US) | 2020-02-05 | — | — | EP | disclosed |
| CN-110709069-A | Methods and compositions for enhancing health | 奥海能量公益公司 | 2020-01-17 | — | — | CN | disclosed |
| WO-2018183115-A1 | METHODS AND COMPOSITIONS FOR ENHANCING HEALTH | OJAI ENERGETICS PBC (US) | 2018-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10981850-B2 | One-step flow-mediated synthesis of cannabidiol (CBD) and derivatives | CNR1, CNR2, SQLE | ALDH1A1 3207/4885MEN1 3583/4885KMT2A 3722/4885 |
| US-20210163387-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | CNR1, CNR2, SQLE | ALDH1A1 3207/4885MEN1 3583/4885KMT2A 3722/4885 |
| US-20260021121-A1 | CANNABIS COMPOSITIONS AND METHODS | CNR2, CNR1, CCT3 | ALDH1A1 4096/4885MEN1 3733/4885KMT2A 3366/4885 |
| US-20200325091-A1 | ONE-STEP FLOW-MEDIATED SYNTHESIS OF CANNABIDIOL (CBD) AND DERIVATIVES | CNR1, CNR2, SQLE | ALDH1A1 3207/4885MEN1 3583/4885KMT2A 3722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.